A. Yacoub

发表

Autocrine loops with positive feedback enable context-dependent cell signaling.

D. Lauffenburger, S. Shvartsman, H. Wiley, 2002, American journal of physiology. Cell physiology.

Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways1

R. Schmidt-Ullrich, J. Contessa, P. Dent, 2003, Radiation research.

The neuro-steroid, 5-androstene 3β,17α diol; induces endoplasmic reticulum stress and autophagy through PERK/eIF2α signaling in malignant glioma cells and transformed fibroblasts.

P. Dent, A. Yacoub, R. Loria, 2010, The international journal of biochemistry & cell biology.

Astrocyte Elevated Gene-1: A Novel Target for Human Glioma Therapy

P. Fisher, K. Shah, J. Bruce, 2010, Molecular Cancer Therapeutics.

Correction to “Poly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells”

P. Dent, A. Yacoub, Chen Yang, 2010 .

Poly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells

P. Dent, A. Yacoub, Chen Yang, 2010, Molecular Pharmacology.

Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivo

John D. Roberts, P. Dent, M. Hagan, 2008, Molecular Cancer Therapeutics.

Transient exposure of mammary tumors to PD184352 and UCN-01 causes tumor cell death in vivo and prolonged suppression of tumor re-growth

John D. Roberts, P. Dent, A. Yacoub, 2005, Cancer biology & therapy.

Mitochondrial Localized Stat3 Promotes Breast Cancer Growth via Phosphorylation of Serine 727*

P. Dent, K. Valerie, A. Yacoub, 2013, The Journal of Biological Chemistry.

Potential molecular mechanism for rodent tumorigenesis: mutational generation of Progression Elevated Gene-3 (PEG-3)

P. Fisher, P. Dent, A. Yacoub, 2005, Oncogene.

17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca2+-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species

P. Fisher, D. Häussinger, P. Dent, 2010, Molecular Cancer Therapeutics.

Molecular Cancer Therapeutics 17-Allylamino-17-Demethoxygeldanamycin and MEK 1 / 2 Inhibitors Kill GI Tumor Cells via Ca 2 +-Dependent Suppression of GRP 78 / BiP and Induction of Ceramide and Reactive Oxygen Species

P. Fisher, D. Häussinger, P. Dent, 2010 .

PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells.

P. Fisher, S. Spiegel, P. Dent, 2010, Cancer research.

17-Allylamino-17-demethoxygeldanamycin enhances the lethality of deoxycholic acid in primary rodent hepatocytes and established cell lines

P. Dent, A. Yacoub, S. Grant, 2007, Molecular Cancer Therapeutics.

Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells

D. Häussinger, P. Dent, A. Yacoub, 2010, Molecular Cancer Therapeutics.

Discovery afenib Activates CD 95 and Promotes Autophagy and Cell Ther th via Src Family Kinases in Gastrointestinal Tumor Cells

D. Häussinger, P. Dent, A. Yacoub, 2010 .

Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation

John D. Roberts, P. Fisher, P. Dent, 2008, Clinical Cancer Research.

Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo

K. Nephew, P. Dent, A. Yacoub, 2010, Cancer biology & therapy.

Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cells

John D. Roberts, P. Fisher, P. Dent, 2007, Molecular Cancer Therapeutics.

OSU-03012 stimulates PERK-dependent increases in HSP 70 expression , attenuating its lethal actions in transformed cells

P. Fisher, S. Spiegel, C. Chen, 2007 .

Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95

P. Fisher, P. Dent, M. Hagan, 2008, Molecular Cancer Therapeutics.

Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24.

P. Fisher, P. Dent, A. Yacoub, 2010, Cancer research.

PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells

P. Fisher, S. Spiegel, P. Dent, 2008, Autophagy.

Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells

P. Fisher, S. Spiegel, P. Dent, 2008, Molecular Cancer Therapeutics.

Primary Human Glioblastoma Multiforme Cells Induced Killing of −-7 / IL-24 mda Thioredoxin Play a Key Role in Dependent Regulation of Ceramide Synthase 6 and −

P. Fisher, S. Spiegel, P. Dent, 2010 .

A Drosophila ribosomal protein contains 8‐oxoguanine and abasic site DNA repair activities.

A. Yacoub, M. Kelley, P. Doetsch, 1996, The EMBO journal.

A Serotype 5/3 Adenovirus Expressing MDA-7/IL-24 Infects Renal Carcinoma Cells and Promotes Toxicity of Agents That Increase Ros and Ceramide Levels

P. Fisher, S. Spiegel, P. Dent, 2011, Molecular Pharmacology.

Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling

P. Fisher, P. Dent, A. Yacoub, 2008, Molecular Cancer Therapeutics.

Low-Dose BBR3610 Toxicity in Colon Cancer Cells Is p53-Independent and Enhanced by Inhibition of Epidermal Growth Factor Receptor (ERBB1)-Phosphatidyl Inositol 3 Kinase Signaling

John D. Roberts, P. Fisher, P. Dent, 2007, Molecular Pharmacology.

Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells

P. Dent, A. Yacoub, S. Grant, 2012, Cancer biology & therapy.

Sequence of a dihydrofolate reductase-encoding gene from Candida albicans.

A. Yacoub, R. Lorenzetti, G. Mastromei, 1994, Gene.

The DNA repair activity of human redox/repair protein APE/Ref-1 is inactivated by phosphorylation.

A. Yacoub, M. Kelley, W. A. Deutsch, 1997, Cancer research.

Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma.

P. Fisher, K. Shah, P. Dent, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity.

P. Fisher, P. Dent, A. Yacoub, 2010, Cytokine & growth factor reviews.

Radiation‐induced PARP activation is enhanced through EGFR‐ERK signaling

P. Dent, M. Hagan, A. Yacoub, 2007, Journal of cellular biochemistry.

Isolation and characterization of a gene encoding alpha-tubulin from Candida albicans.

A. Yacoub, R. Lorenzetti, G. Mastromei, 1997, Gene.

Cloning and partial characterization of an avirulence determinant from race 1 of Pseudomonas syringae pv. phaseolicola

A. Yacoub, D. Kluepfel, M. Shintaku, 1989 .

The switch from DNA repair to apoptosis: discovery of a refractory period for radiation-induced EGFR-MAPK signaling following irradiation

P. Dent, M. Hagan, A. Yacoub, 2003 .

Inhibition of vimentin or B1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo

Z. Zehner, M. Bissell, M. Fournier, 2010 .

Neuroprotective effects of perflurocarbon (oxycyte) after contusive spinal cord injury.

A. Yacoub, B. Mathern, H. Young, 2014, Journal of neurotrauma.

Effects of Enhanced Oxygen Delivery by Perfluorocarbons in Spinal Cord Injury

A. Yacoub, B. Mathern, Marygrace C. Hajec, 2013 .

Epidermal Growth Factor and Ionizing Radiation Up-regulate the DNA Repair Genes XRCC1 and ERCC1 in DU145 and LNCaP Prostate Carcinoma through MAPK Signaling

P. Dent, M. Hagan, A. Yacoub, 2003, Radiation research.

MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion

P. Dent, M. Hagan, A. Yacoub, 2001, International journal of radiation biology.

Hepatitis B virus X protein increases expression of p21Cip‐1/WAF1/MDA6 and p27Kip‐1 in primary mouse hepatocytes, leading to reduced cell cycle progression

P. Fisher, P. Dent, A. Yacoub, 2001 .

The yeast 8-oxoguanine DNA glycosylase (Ogg1) contains a DNA deoxyribophosphodiesterase (dRpase) activity.

A. Yacoub, W. Franklin, M. Kelley, 1997, Nucleic acids research.

Correction to: “Human Chorionic Gonadotropin Modulates Prostate Cancer Cell Survival after Irradiation or HMG CoA Reductase Inhibitor Treatment”

John D. Roberts, P. Fisher, P. Dent, 2016, Molecular Pharmacology.

Lapatinib Resistance in HCT116 Cells Is Mediated by Elevated MCL-1 Expression and Decreased BAK Activation and Not by ERBB Receptor Kinase Mutation

P. Fisher, P. Dent, M. Hagan, 2008, Molecular Pharmacology.

MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacity.

W. Linehan, P. Fisher, P. Dent, 2003, Molecular cancer therapeutics.

Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKCδ Signaling Axis*

Ngoc Thang Vu, P. Fisher, P. Dent, 2016, The Journal of Biological Chemistry.

MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors

P. Fisher, K. Shah, P. Dent, 2008, Cancer biology & therapy.

H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent.

P. Dent, M. Hagan, A. Yacoub, 2005, Molecular cancer therapeutics.

CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.

Yun Dai, Paul Dent, P. Fisher, 2011, Molecular interventions.

Response and Resistance to Ionizing Radiation

P. Dent, M. Hagan, A. Yacoub, 2006 .

MAPK pathways in radiation responses

Paul Dent, P. Fisher, P. Dent, 2003, Oncogene.

Radiation-induced cell signaling: inside-out and outside-in

P. Fisher, P. Dent, K. Valerie, 2007, Molecular Cancer Therapeutics.

Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokine.

P. Fisher, John Calvin Reed, P. Dent, 2010, Cancer research.

Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells.

P. Fisher, K. Nephew, P. Dent, 2011, Cancer research.

Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance.

G. Mills, P. Wipf, P. Dent, 2009, Cancer research.

OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killing

P. Dent, A. Yacoub, S. Grant, 2012, Cancer biology & therapy.

Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway.

P. Fisher, S. Spiegel, D. Häussinger, 2010, Cancer research.

Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death

P. Dent, A. Yacoub, S. Grant, 2011, Cancer biology & therapy.

Inhibition of vimentin or β1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo

Z. Zehner, M. Bissell, M. Fournier, 2009, Molecular Cancer Therapeutics.

Inhibition of vimentin or β1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo

Z. Zehner, M. Bissell, M. Fournier, 2009, Molecular Cancer Therapeutics.

Drosophila ribosomal protein PO contains apurinic/apyrimidinic endonuclease activity.

A. Yacoub, M. Kelley, W. A. Deutsch, 1996, Nucleic acids research.

RLIP76 in defense of radiation poisoning.

Sumihiro Suzuki, D. Armstrong, P. Dent, 2008, International journal of radiation oncology, biology, physics.

RLIP76 is a major determinant of radiation sensitivity.

P. Dent, A. Yacoub, P. Boor, 2005, Cancer research.

MDA-7 regulates cell growth and radiosensitivity in vitro of primary (Non-Established) human glioma cells

P. Fisher, P. Dent, A. Yacoub, 2004, Cancer biology & therapy.

Radiotherapy-induced signal transduction.

P. Fisher, P. Dent, M. Hagan, 2006, Endocrine-related cancer.

Inhibitors of MEK1/2 Interact with UCN-01 to Induce Apoptosis and Reduce Colony Formation in Mammary and Prostate Carcinoma Cells

P. Dent, A. Yacoub, S. Grant, 2002, Cancer biology & therapy.

Activated NKT Cells and NK Cells Render T Cells Resistant to Myeloid-Derived Suppressor Cells and Result in an Effective Adoptive Cellular Therapy against Breast Cancer in the FVBN202 Transgenic Mouse

Lisa L. Smith, H. Bear, A. Yacoub, 2011, The Journal of Immunology.

Inhibition of insulin/IGF-1 receptor signaling enhances bile acid toxicity in primary hepatocytes.

J. Grandis, P. Dent, A. Yacoub, 2005, Biochemical pharmacology.

Pharmocologic Inhibitors of the Mitogen Activated Protein Kinase Cascade Have the Potential to Interact with Ionizing Radiation Exposure to Induce Cell Death in Carcinoma Cells by Multiple Mechanisms

P. Fisher, P. Dent, M. Hagan, 2002, Cancer biology & therapy.

Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways

G. Duigou, C. S. Young, P. Fisher, 2001, Oncogene.

Ionizing Radiation Causes a Dose-Dependent Release of Transforming Growth Factor α In vitro from Irradiated Xenografts and during Palliative Treatment of Hormone-Refractory Prostate Carcinoma

P. Dent, M. Hagan, A. Yacoub, 2004, Clinical Cancer Research.

Histone Deacetylase Inhibitors Interact with Melanoma Differentiation Associated-7/Interleukin-24 to Kill Primary Human Glioblastoma Cells

P. Fisher, P. Dent, A. Yacoub, 2013, Molecular Pharmacology.

Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery

P. Fisher, P. Dent, A. Yacoub, 2010, Cancer biology & therapy.

The development of MDA-7/IL-24 as a cancer therapeutic.

P. Fisher, P. Dent, A. Yacoub, 2010, Pharmacology & therapeutics.

MDA-7/IL-24 as a cancer therapeutic: from bench to bedside

P. Fisher, P. Dent, A. Yacoub, 2010, Anti-cancer drugs.

OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins

P. Fisher, P. Dent, A. Yacoub, 2010, Cancer biology & therapy.

Cisplatin Enhances Protein Kinase R-Like Endoplasmic Reticulum Kinase- and CD95-Dependent Melanoma Differentiation-Associated Gene-7/Interleukin-24–Induced Killing in Ovarian Carcinoma Cells

P. Fisher, P. Dent, A. Yacoub, 2010, Molecular Pharmacology.

MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanism

P. Fisher, S. Spiegel, P. Dent, 2009, Molecular Cancer Therapeutics.

Cisplatin enhances PERK- and CD95-dependent MDA-7/IL-24-induced killing in ovarian carcinoma cells

P. Fisher, P. Dent, A. Yacoub, 2009 .

mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).

S. Inoue, P. Fisher, R. Ramesh, 2007, International journal of oncology.

MDA‐7/IL‐24 regulates proliferation, invasion and tumor cell radiosensitivity: A new cancer therapy?

Paul Dent, P. Fisher, P. Dent, 2005, Journal of cellular biochemistry.

mda-7/IL-24: exploiting cancer's Achilles' heel.

P. Fisher, J. Nemunaitis, P. Dent, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo.

P. Fisher, P. Dent, A. Yacoub, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

mda-7 (IL-24) Inhibits Growth and Enhances Radiosensitivity of Glioma Cells In Vitro via JNK Signaling

P. Fisher, P. Dent, A. Yacoub, 2003, Cancer biology & therapy.

Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner

P. Fisher, P. Dent, K. Valerie, 2003, Oncogene.

Mechanistic aspects of mda-7/IL-24 cancer cell selectivity analysed via a bacterial fusion protein

P. Fisher, P. Dent, A. Yacoub, 2004, Oncogene.

Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells

Z. Su, P. Fisher, P. Dent, 2010, Cancer Gene Therapy.

Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms

P. Houghton, P. Dent, A. Yacoub, 2009, Molecular Pharmacology.

Searching for a cure: Gene therapy for glioblastoma

P. Fisher, K. Shah, P. Dent, 2008, Cancer biology & therapy.

OSU-03012 Stimulates PKR-Like Endoplasmic Reticulum-Dependent Increases in 70-kDa Heat Shock Protein Expression, Attenuating Its Lethal Actions in Transformed Cells

P. Fisher, S. Spiegel, P. Dent, 2008, Molecular Pharmacology.

OSU-03012 Promotes Caspase-Independent but PERK-, Cathepsin B-, BID-, and AIF-Dependent Killing of Transformed Cells

P. Dent, A. Yacoub, S. Grant, 2006, Molecular Pharmacology.

Inhibition of the MAPK and PI3K pathways enhances UDCA‐induced apoptosis in primary rodent hepatocytes

P. Dent, A. Yacoub, S. Grant, 2002, Hepatology.

Time course of apoptosis and proliferation in vascular smooth muscle cells after balloon angioplasty

A. Angelini, G. Thiene, A. Yacoub, 2002 .

Is a Major Determinant of Radiation Sensitivity

P. Dent, A. Yacoub, P. Boor, 2005 .

The Drosophila Ribosomal Protein S3 Contains a DNA Deoxyribophosphodiesterase (dRpase) Activity*

A. Yacoub, W. Franklin, M. Kelley, 1997, The Journal of Biological Chemistry.

Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival.

P. Dent, M. Hagan, A. Yacoub, 2005, Molecular cancer therapeutics.

Human chorionic gonadotropin (hCG) interacts with lovastatin and ionizing radiation to modulate prostate cancer cell viability in vivo

P. Dent, A. Yacoub, S. Grant, 2008, Cancer biology & therapy.

DMC: Novel celecoxib derivatives to rap cancer

P. Dent, A. Yacoub, S. Grant, 2005, Cancer biology & therapy.

Radiation-Stimulated ERK1/2 and JNK1/2 Signaling can Promote Cell Cycle Progression in Human Colon Cancer Cells

P. Dent, M. Hagan, A. Yacoub, 2005, Cell cycle.

Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.

P. Dent, J. Park, A. Yacoub, 2001, Hepatology.

Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis

P. Fisher, P. Dent, A. Yacoub, 2005, Oncogene.

Cancer in the FVBN202 Transgenic Mouse Adoptive Cellular Therapy against Breast Suppressor Cells and Result in an Effective Cells Resistant to Myeloid-Derived Activated NKT Cells and NK Cells Render T

Lisa L. Smith, H. Bear, A. Yacoub, 2011 .

Transgenic Mouse Therapy against Breast Cancer in the FVBN202 Cells and Result in an Effective Adoptive Cellular Cells Resistant to Myeloid-Derived Suppressor Activated NKT Cells and NK Cells Render T

Lisa L. Smith, A. Yacoub, K. Payne, 2011 .

MEK1/2 inhibition promotes Taxotere® lethality in mammary tumors in vivo

P. Fisher, P. Dent, M. Hagan, 2006, Cancer biology & therapy.

Sequence Dependent Exposure of Mammary Carcinoma Cells to Taxotere® and the MEK1/2 Inhibitor U0126 Causes Enhanced Cell Killing In Vitro

P. Dent, A. Yacoub, R. Carón, 2003, Cancer biology & therapy.

Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways

G. Duigou, C. S. Young, P. Fisher, 2001, Oncogene.

Human Chorionic Gonadotropin Modulates Prostate Cancer Cell Survival after Irradiation or HMG CoA Reductase Inhibitor Treatment

John D. Roberts, P. Fisher, P. Dent, 2007, Molecular Pharmacology.

Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24.

P. Fisher, P. Dent, A. Yacoub, 2010, Cancer research.

Searching for a cure: Gene therapy for glioblastoma

P. Fisher, K. Shah, P. Dent, 2008, Cancer biology & therapy.

Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivo

John D. Roberts, P. Dent, M. Hagan, 2008, Molecular Cancer Therapeutics.

Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms

P. Houghton, P. Dent, A. Yacoub, 2009, Molecular Pharmacology.

Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo

P. Dent, A. Yacoub, Chen Yang, 2010, Cancer biology & therapy.